Nosocomial infection caused by methicillin-resistant Staphylococcus aureus in Palestine

被引:15
|
作者
Adwan, K [1 ]
Abu-Hasan, N [1 ]
Adwan, G [1 ]
Jarrar, N [1 ]
Abu-Shanab, B [1 ]
Abu-Zant, A [1 ]
机构
[1] An Najah N Univ, Dept Biol Sci, Nablus, Palestine, Israel
关键词
D O I
10.1089/mdr.2005.11.75
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This report presents the prevalence of Palestinian isolates of methicillin-resistant Staphylococcus aureus (MRSA) in nosocomial infections and their antibiotic resistant pattern. A total of 321 clinical isolates of S. aureus were identified from different patients. The prevalence of methicillin resistance among S. aureus isolates was 8.7% (28 isolates). Resistance rates of MRSA to other antibiotics were as follows: 82.1% resistant to erytbromycin, 67.9% to clindamycin, 64.3% to gentamicin, and 32.1% to ciprofloxacin. No co-trimoxazole- and vancomvcin-resistant isolates were identified in this study. The proportion of methicillin resistance was highest among S. aureus isolates associated with upper respiratory specimens (42.8%); the proportion of methicillin resistance was 39.3% among skin ulcer isolates, 10.7% among urinary tract infection isolates, and lowest among isolates associated with blood and prostate discharge (3.6% each).
引用
收藏
页码:75 / 77
页数:3
相关论文
共 50 条
  • [1] Control of nosocomial methicillin-resistant Staphylococcus aureus infection
    Muto, CA
    Vos, MC
    Jarvis, WR
    Farr, BM
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (03) : 387 - 388
  • [2] Investigation of nosocomial infection caused by arbekacin-resistant, methicillin-resistant Staphylococcus aureus
    Obayashi, Y
    Fujita, J
    Ichiyama, S
    Hojo, S
    Negayama, K
    Takashima, C
    Miyawaki, H
    Tanabe, T
    Yamaji, Y
    Kawanishi, K
    Takahara, J
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 28 (02) : 53 - 59
  • [3] EPIDEMIOLOGY OF NOSOCOMIAL INFECTIONS CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    THOMPSON, RL
    CABEZUDO, I
    WENZEL, RP
    [J]. ANNALS OF INTERNAL MEDICINE, 1982, 97 (03) : 309 - 317
  • [4] Risk factors of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Torre-Cisneros, Julian
    Tejero Garcia, Rocio
    Natera Kindelan, Clara
    Font Ugalde, Pilar
    Franco Alvarez de Luna, Francisco
    Caston Osorio, Juan Jose
    Rivero Roman, Antonio
    Casal Roman, Manuel
    [J]. MEDICINA CLINICA, 2012, 138 (03): : 99 - 106
  • [5] Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Thamlikitkul, Visanu
    Tongsai, Sasima
    [J]. CHEST, 2012, 142 (01) : 269 - 270
  • [6] Methicillin-resistant Staphylococcus aureus nosocomial infection in a maternity ward.
    Le Coq, M
    Simon, I
    Sire, C
    Tissot-Guerraz, F
    Fournier, L
    Aho, S
    Noblot, G
    Reverdy, ME
    Françoise, M
    [J]. PATHOLOGIE BIOLOGIE, 2001, 49 (01): : 16 - 22
  • [7] Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
    Hooper, Candace Y.
    Smith, Winter J.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 131 - 137
  • [8] Pharmacotherapy for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Segarra-Newnham, Marisel
    Church, Timothy J.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (12) : 1678 - 1687
  • [9] Histochemical identification of Methicillin-resistant Staphylococcus aureus:: contribution to preventing nosocomial infection
    Shimomura, Ryoichi
    Tsutsumi, Yutaka
    [J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2007, 24 (04) : 217 - 226
  • [10] Prevention and control of methicillin-resistant Staphylococcus aureus nosocomial infection in Barcelona (Spain)
    Trilla, A
    Marco, F
    Moreno, AV
    Prat, A
    Vila, J
    Bayas, JM
    deAnta, MTJ
    [J]. CHEMOTHERAPY, 1996, 42 : 53 - 59